The Herston Infectious Diseases Institute (HeIDI) aims to deliver innovative infectious diseases research that achieves clinical excellence in the surveillance, diagnosis and management of serious infections that impact on our community, prevents and monitors healthcare-associated infections, and promotes partnerships between industry, government and academic institutions.
HeIDI is based on the Herston Precinct – a precinct with a history of clinical excellence, education and research spanning over 150 years and home to many of Queensland’s major infectious diseases and microbiology services and resources. By harnessing this exciting critical mass of talented, multi-disciplinary infectious diseases researchers and clinicians on the Herston Precinct, HeIDI will deliver on a platform built of a combination of mature, existing capabilities.
The vision for HeIDI is to be a world-class, collaborative clinical research institute, evaluating and translating novel diagnostic, therapeutic and management innovations into evidence informed clinical practice – our three core functions are translational research, education and clinical excellence. We aim to integrate academic, research, industry and government partners across a shared clinical research agenda, leveraging the strengths of partner organisations to deliver this vision.
In pursuing this vision, the Institute will:
- enhance the translational and clinical research response to the current and future pandemics, and preparedness for future pandemics caused by known and novel agents
- improve the outcomes of patients with serious infections at all Metro North facilities and across Queensland and Australia
- lead the prevention and monitoring of healthcare-associated infections throughout Queensland
- leverage further grant and philanthropic funding for the Herston Precinct by undertaking world leading research in clinical infectious diseases
- create a legacy by training the next generation of infectious diseases clinicians and researchers.
Download the Herston Infectious Diseases Institute (HeIDI) Strategic Plan 2020-24.